Elder Pharma Ltd is a 'BUY' call with a target of Rs 230 and a stop loss of Rs 195.

Elder Pharma is a ‘BUY’ call with a target of Rs 252 and a stop loss of Rs 222.

Elder Pharmaceuticals has appointed consulting firm Deloitte for restructuring the company and its brands including ‘Eldervit’.

Buy Elder Pharma Ltd with a target of Rs 345 and a stop loss of Rs 306: Sandeep Wagle.

Torrent Pharma is said to have offered Rs 1700 crores for buying the whole of India business of Elder Pharma.

The stock had rallied over 13 per cent on Thursday on rumours that Sanofi SA’s Indian arm was close to buy out Elder Pharma’s domestic form...

"Elder Pharma Ltd is a ‘BUY’ call with a target of Rs 360 and a stop loss of Rs 317."

Sanofi has emerged as the highest bidder for the domestic formulation business of Elder Pharma, ahead of Pfizer and Glaxo.

"Elder Pharma Ltd is a ‘BUY’ call with a target of Rs 385 and a stop loss of Rs 353."

Elder Pharma rallied 5%, after the pharma major said that its UK arm NutraHealth has acquired West Yorkshire-based firm Max Healthcare.

Elder Pharma was locked in upper circuit at Rs 311.05, up 5%. Novartis was trading 0.4% higher at Rs 467, while Sanofi India was down 0.5% ...

Buy Elder Pharma Ltd with a stop loss of about Rs 380 and look for a price target of Rs 405.

The company's annual turnover for the last year stood at $1.12 billion and it employs more than 800 people across countries.

"Elder Pharma Ltd is a buy with a target price of Rs 440 and a stop loss of Rs 395."

Elder Pharma today said its consolidated net profit rose by 22 per cent to Rs 23.60 crore in the July-September quarter.

Elder Pharmaceuticals plans to increase its sales and marketing force by 1,000 in the next two years, as it plans to launch 35 new products.

Roche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.